Efficacy of Trastuzumab + Cisplatin Combined with Irinotecan on the Quality of Life of Patients with Advanced Her-2 Positive Gastric Cancer

Table 3

Comparison of the quality-of-life scores of the two groups of patients.

Dimensions	Memory function		Body function		Behavioral function		Emotional function		Communicative function
	Before treatment	After treatment	Before treatment	After treatment	Before treatment	After treatment	Before treatment	After treatment	Before treatment	After treatment
Control group	15.16 ± 2.35	56.11 ± 5.62	16.25 ± 2.51	58.17 ± 6.05	13.97 ± 2.44	44.72 ± 5.30	17.26 ± 2.58	55.26 ± 6.15	14.63 ± 2.27	50.23 ± 5.19
Joint group	14.86 ± 2.41	77.81 ± 8.03	16.18 ± 2.46	70.56 ± 7.71	14.06 ± 2.83	70.12 ± 6.85	17.33 ± 3.01	72.59 ± 8.01	15.02 ± 2.35	69.58 ± 7.13
t	12.010	17.150	11.202	9.793	10.031	22.717	9.020	13.293	7.521	16.996
	0.372	<0.001	0.802	<0.001	0.600	<0.001	0.701	<0.001	0.865	<0.001